Home › Lung Cancer › NCT03029325
Boston Lung Cancer Study (Molecular and Genetic Analysis of Lung Cancer)
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: -cases: pathology proven primary lung cancer Exclusion Criteria: * younger than 18 years old
About the study
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
Sponsor: Massachusetts General Hospital · Participants: 15,000 · Started: 1993-06
Contact the study team
- David Christiani, MD · Phone: 617-726-9274
- Andrea Shafer, MPH · Phone: 6177269274
Official record on ClinicalTrials.gov — NCT03029325
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.